Spectrum Pharmaceuticals (SPPI) Announces Patent Litigation with GlaxoSmithKline (GSK) has been Dismissed
Tweet Send to a Friend
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) announced that patent litigation relating to sumatriptan injection, the generic version of GlaxoSmithKline's (NYSE: GSK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
